INT J DRUG POLICY - International Journal of Drug Policy

Publications

  1. 2023
  2. Social disparities in alcohol's harm to others: evidence from 32 European countries

    Kilian, C., Manthey, J., Braddick, F., López-Pelayo, H. & Rehm, J., 08.2023, In: INT J DRUG POLICY. 118, p. 104079

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review

    Manthey, J., Jacobsen, B., Hayer, T., Kalke, J., López-Pelayo, H., Pons-Cabrera, M. T., Verthein, U. & Rosenkranz, M., 06.2023, In: INT J DRUG POLICY. 116, p. 104039

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  4. Unrecorded alcohol use in 33 European countries: Analyses of a comparative survey with 49,000 people who use alcohol

    Manthey, J., Braddick, F., López-Pelayo, H., Shield, K., Rehm, J. & Kilian, C., 06.2023, In: INT J DRUG POLICY. 116, p. 104028

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. "Harm per litre" as a concept and a measure in studying determinants of relations between alcohol consumption and harm

    Room, R. & Rehm, J., 05.2023, In: INT J DRUG POLICY. 115, p. 104006

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. What is a public health approach to substance use? A qualitative systematic review and thematic synthesis

    Crépault, J-F., Russell, C., Watson, T. M., Strike, C., Bonato, S. & Rehm, J., 02.2023, In: INT J DRUG POLICY. 112, p. 103958

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  7. The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions

    Russell, C., Law, J., Bonn, M., Rehm, J. & Ali, F., 01.2023, In: INT J DRUG POLICY. 111, p. 103933

    Research output: SCORING: Contribution to journalComment/debateResearch

  8. 2021
  9. Standard units for cannabis dose. Why is it important to standardize cannabis dose for drug policy and how can we enhance its place on the public health agenda?

    López-Pelayo, H., Matrai, S., Balcells-Olivero, M., Campeny, E., Braddick, F., Bossong, M. G., Cruz, O. S., Deluca, P., Dom, G., Feingold, D., Freeman, T. P., Guzman, P., Hindocha, C., Kelly, B. C., Liebregts, N., Lorenzetti, V., Manthey, J., Matias, J., Oliveras, C., Pons, M. T., Rehm, J., Rosenkranz, M., Swithenbank, Z., van Deurse, L., Vicente, J., Vuolo, M., Wojnar, M. & Gual, A., 11.2021, In: INT J DRUG POLICY. 97, 103350.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  10. 2019
  11. Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand?

    Rehm, J., Elton-Marshall, T., Sornpaisarn, B. & Manthey, J., 12.2019, In: INT J DRUG POLICY. 74, p. 47-51 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Cannabis use in Europe. Current trends and public health concerns

    Manthey, J., 06.2019, In: INT J DRUG POLICY. 68, p. 93-96 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  13. 2017
  14. Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs

    Grebely, J., Bruneau, J., Lazarus, J. V., Dalgard, O., Bruggmann, P., Treloar, C., Hickman, M., Hellard, M., Roberts, T., Crooks, L., Midgard, H., Larney, S., Degenhardt, L., Alho, H., Byrne, J., Dillon, J. F., Feld, J. J., Foster, G., Goldberg, D., Lloyd, A. R., Reimer, J., Robaeys, G., Torrens, M., Wright, N., Maremmani, I., Norton, B. L., Litwin, A. H., Dore, G. J. & International Network on Hepatitis in Substance Users, 09.2017, In: INT J DRUG POLICY. 47, p. 51-60 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. 2016
  16. Non-prescribed use of opioid substitution medication Patterns and trends in sub-populations of opioid users in Germany

    Schulte, B., Schmidt, C. S., Strada, L., Götzke, C., Hiller, P., Fischer, B. & Reimer, J., 03.2016, In: INT J DRUG POLICY. 29, p. 57-65 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. 2013
  18. Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability

    Schmidt, C. S., Schulte, B., Wickert, C., Thane, K., Kuhn, S., Verthein, U. & Reimer, J., 01.11.2013, In: INT J DRUG POLICY. 24, 6, p. e111-4

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. 2011
  20. Use of gelatine capsules for application of methamphetamine: a new harm reduction approach.

    Mravčík, V., Skařupová, K., Orlíková, B., Zábranský, T., Karachaliou, K. & Schulte, B., 2011, In: INT J DRUG POLICY. 22, 2, p. 172-173 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. 2009
  22. Drinking before going out--a predictor of negative nightlife experiences in a German inner city area.

    Wahl, S., Kriston, L. & Berner, M., 2009, In: INT J DRUG POLICY.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review